Table 1 Baseline and scanning characteristics
From: Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study
Patient number | Gender F = female M = male | Age (y) | EGFR mutation present, y = yes n = no | [18F]Afatinib scanning protocol | [15O]H2O scanning protocol |
|---|---|---|---|---|---|
1 | M | 68 | Y | 1 | N |
2 | F | 69 | N | 2 | Y |
3 | M | 51 | Y | 2 | Y |
4 | M | 69 | Y | 2 | Y |
5 | F | 57 | Y | 2 | Y |
6 | F | 53 | Y | 3 | N |
7 | M | 71 | N | 3 | Y |
8 | M | 71 | N | 3 | Y |
9 | F | 47 | Y | 3 | Y |
10 | F | 68 | Y | 3 | Y |